Product Information
PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0895 per EA under NDC 00093727256. Its NADAC has been published 582 times since May 13, 2015.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093727256
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077210On Market Since
2/4/2015
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 582 times since May 13, 2015, and over the history we have for it it has declined 61.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0895 per EA |
|---|---|
| All-time high | $0.2319 (May 13, 2015) |
| All-time low | $0.0828 (Nov 20, 2024) |
| 52-week high | $0.1019 |
| 52-week low | $0.0895 |
| Median price | $0.1243 |
| Average price | $0.1366 |
| Largest weekly change | +24.7% (Jun 19, 2024) |
| Weeks tracked | 582 |
| Tracking since | May 13, 2015 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0895 per EA (NDC 00093727256), effective Jul 1, 2026.
How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has declined 61.4%. It has been tracked across 582 weekly CMS publications since May 13, 2015.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?
Since May 13, 2015, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.0828 (Nov 20, 2024) to a high of $0.2319 (May 13, 2015), with a median of $0.1243 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as PIOGLITAZONE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures PIOGLITAZONE HCL 30 MG TABLET?
PIOGLITAZONE HCL 30 MG TABLET (NDC 00093727256) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification